Heat shock protein peptide complex-96 vaccination for newly diagnosed glioblastoma: a phase I, single-arm trial

BACKGROUND. Heat shock protein peptide complex-96 (HSPPC-96) triggers adaptive and innate antitumor immune responses. The safety and efficacy of HSPPC-96 vaccination was examined in patients with newly diagnosed glioblastoma multiforme (GBM). METHODS. In this open-label, single-arm, phase I study, a...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:JCI Insight
Main Authors: Ji, Nan, Zhang, Yang, Liu, Yunpeng, Xie, Jian, Wang, Yi, Hao, Shuyu, Gao, Zhixian
Format: Artigo
Sprog:Inglês
Udgivet: American Society for Clinical Investigation 2018
Fag:
Clinical Medicine
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6012501/
https://ncbi.nlm.nih.gov/pubmed/29769450
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.99145
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker